Clearside Biomedical Inc buy Wedbush
Start price
13.03.24
/
50%
€1.59
Target price
13.03.25
€3.66
Performance (%)
-14.47%
Price
04.10.24
€1.21
Summary
This prediction is currently active. The prediction for Clearside Biomedical Inc disappoints with a performance of -14.47%. This prediction currently runs until 13.03.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Clearside Biomedical Inc | 21.000% | 21.000% |
iShares Core DAX® | -1.114% | 5.062% |
iShares Nasdaq 100 | 1.816% | 9.828% |
iShares Nikkei 225® | 2.113% | 8.218% |
iShares S&P 500 | 2.038% | 7.448% |
Comments by Wedbush for this prediction
In the thread Clearside Biomedical Inc diskutieren
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $5.00.
Ratings data for CLSD provided by MarketBeat
Stopped prediction by Wedbush for Clearside Biomedical Inc
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€0.89
15.08.23
15.08.23
€4.58
15.08.24
15.08.24
6.78%
16.08.24
16.08.24